Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Medical Solutions (AMS) is a global leader in the development and manufacture of innovative wound care and surgical products, most notably the LiquiBand range of medical adhesives. The LiquiBand portfolio utilizes cyanoacrylate technology to provide secure and effective topical closure for surgical incisions and traumatic lacerations, serving as an alternative to traditional sutures and staples. Beyond wound closure, AMS offers a broad array of products including silver alginates, foams, and collagen-based dressings for advanced wound care. The company's surgical division also features the LiquiBand Fix8 device, which is used for the internal fixation of hernia meshes. Headquartered in the United Kingdom, AMS operates multiple manufacturing and R&D facilities and distributes its products in over 80 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LiquiBand.